Extract
The primary objective of the study is to determine the maximum tolerated dose (MTD) of CEP-9722 in combination with gemcitabine and cisplatin in patients with advanced solid tumors or mantle cell lymphoma.
Inclusion criteria
- Solid Tumors or Mantle Cell Lymphoma